0001209191-23-035044.txt : 20230607 0001209191-23-035044.hdr.sgml : 20230607 20230607160614 ACCESSION NUMBER: 0001209191-23-035044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230606 FILED AS OF DATE: 20230607 DATE AS OF CHANGE: 20230607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COUGHLIN TIMOTHY CENTRAL INDEX KEY: 0001376043 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36076 FILM NUMBER: 23999017 MAIL ADDRESS: STREET 1: 339 NORTH GRANADOS AVE CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER NAME: FORMER CONFORMED NAME: Coughlin Timothy P DATE OF NAME CHANGE: 20060919 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FATE THERAPEUTICS INC CENTRAL INDEX KEY: 0001434316 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 651311552 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 BUSINESS PHONE: 858.875.1803 MAIL ADDRESS: STREET 1: 12278 SCRIPPS SUMMIT DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92131 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-06 0 0001434316 FATE THERAPEUTICS INC FATE 0001376043 COUGHLIN TIMOTHY C/O FATE THERAPEUTICS, INC.; 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 1 0 0 0 0 Stock Option (Right to Buy) 5.52 2023-06-06 4 A 0 40000 0.00 A 2033-06-06 Common Stock 40000 40000 D This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The shares subject to this option shall vest and become exercisable on the earlier of (i) June 6, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors. /s/ Cindy Tahl, as Attorney-in-Fact 2023-06-07